{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:46:57Z","timestamp":1791298017397,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neuropharm.2015.10.021","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T14:22:40Z","timestamp":1445696560000},"page":"460-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice"],"prefix":"10.1016","volume":"101","author":[{"given":"G.","family":"Madeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maltese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Martella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rapino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bonsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3990-2963","authenticated-orcid":false,"given":"M.","family":"Maccarrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2015.10.021_bib1","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","article-title":"PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation","volume":"128","author":"Adams","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neuropharm.2015.10.021_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1460-9568.2008.06551.x","article-title":"Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synapticactivity","volume":"29","author":"Adermark","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib3","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1523\/JNEUROSCI.20-09-03401.2000","article-title":"Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor","volume":"20","author":"Beltramo","year":"2000","journal-title":"J.\u00a0Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.10.021_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jnc.12139","article-title":"Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and \u03b4 opioid systems","volume":"124","author":"Blume","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","article-title":"Early-onset parkinsonism associated with PINK1 mutations. Frequency, genotypes and phenotypes","volume":"65","author":"Bonifati","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jpsychires.2010.03.002","article-title":"Methamphetamine neurotoxicity increase brain expression and alters behavioural functions of CB1 cannabinoid receptors","volume":"44","author":"Bortolato","year":"2010","journal-title":"J.\u00a0Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2015.10.021_bib7","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1523\/JNEUROSCI.12-11-04224.1992","article-title":"Long-term synaptic depression in the striatum: physiological and pharmacological characterization","volume":"12","author":"Calabresi","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib8","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1523\/JNEUROSCI.17-12-04536.1997","article-title":"Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors","volume":"17","author":"Calabresi","year":"1997","journal-title":"J.\u00a0Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2015.10.021_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","article-title":"Dopamine-mediated regulation of corticostriatal synaptic plasticity","volume":"30","author":"Calabresi","year":"2007","journal-title":"Trends Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2015.10.021_bib10","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/sj.npp.1300458","article-title":"A\u00a0critical interaction between dopamine D2 receptorsand endocannabinoids mediates the effects of cocaine on striatal gabaergic transmission","volume":"29","author":"Centonze","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib11","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.neuropharm.2015.10.021_bib12","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1523\/JNEUROSCI.3695-07.2007","article-title":"The roles of kinases in familial Parkinson's disease","volume":"27","author":"Cookson","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.10.021_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-3223(02)01730-4","article-title":"Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents","volume":"54","author":"Cryan","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2015.10.021_bib14","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1471-4159.2009.06036.x","article-title":"Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment","volume":"109","author":"Cuomo","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib15","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1523\/JNEUROSCI.1683-10.2010","article-title":"Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum","volume":"30","author":"De Chiara","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib16","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.0803998105","article-title":"The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and\/or inhibit fusion in Drosophila","volume":"105","author":"Deng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.neuropharm.2015.10.021_bib17","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2174\/138161208785740072","article-title":"The endocannabinoid system in Parkinson's disease","volume":"14","author":"Di Filippo","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib18","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib19","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/jm900255t","article-title":"Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity","volume":"52","author":"Dow","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1212\/WNL.0b013e3181e0f79c","article-title":"Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit","volume":"74","author":"Eggers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib21","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1523\/JNEUROSCI.0719-07.2007","article-title":"Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin","volume":"27","author":"Exner","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2015.10.021_bib22","first-page":"1372","article-title":"Subclinical sensory abnormalities in unaffected PINK1 heterozygotes","volume":"255","author":"Fiorio","year":"2008","journal-title":"J.\u00a0Neurol."},{"issue":"10","key":"10.1016\/j.neuropharm.2015.10.021_bib23","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1210\/en.2009-0057","article-title":"Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability","volume":"150","author":"Francavilla","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib24","first-page":"269","article-title":"Cannabinoid CB1 receptors are early downregulated followed by a further upregulation in the basal ganglia of mice with deletion of specific park genes","author":"Garc\u00eda-Arencibia","year":"2009","journal-title":"J.\u00a0Neural Transm. Suppl."},{"issue":"15","key":"10.1016\/j.neuropharm.2015.10.021_bib25","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1016\/j.bmcl.2010.06.050","article-title":"A\u00a0new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase","volume":"20","author":"Gattinoni","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib26","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nn832","article-title":"Postsynaptic endocannabinoid release is critical to long-term depression in the striatum","volume":"5","author":"Gerdeman","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2015.10.021_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0705466","article-title":"Emerging roles for endocannabinoids in long-term synaptic plasticity","volume":"140","author":"Gerdeman","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib30","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1471-4159.2006.04186.x","article-title":"Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL\/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels","volume":"99","author":"Giordano","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2015.10.021_bib32","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"10.1016\/j.neuropharm.2015.10.021_bib33","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J.\u00a0Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in\u00a0vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J.\u00a0Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.10.021_bib35","article-title":"Endocannabinoid signaling is critical for habit formation","volume":"1","author":"Hilario","year":"2007","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1469-7793.2001.0731e.x","article-title":"Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons","volume":"532","author":"Huang","year":"2001","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/brain\/awl005","article-title":"Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa","volume":"129","author":"Ibanez","year":"2006","journal-title":"Brain"},{"issue":"7305","key":"10.1016\/j.neuropharm.2015.10.021_bib38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature09263","article-title":"Start\/stop signals emerge in nigrostriatal circuits during sequence learning","volume":"466","author":"Jin","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib39","article-title":"Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species","volume":"1","author":"Johnston","year":"2004","journal-title":"Cerebrospinal Fluid Res."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib40","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib41","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1523\/JNEUROSCI.0309-06.2006","article-title":"Molecular composition of the endocannabinoid system at glutamatergic synapses","volume":"26","author":"Katona","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib42","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awf237","article-title":"Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study","volume":"125","author":"Khan","year":"2002","journal-title":"Brain"},{"issue":"27","key":"10.1016\/j.neuropharm.2015.10.021_bib43","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice","volume":"104","author":"Kitada","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1474-4422(07)70174-6","article-title":"Deciphering the role of heterozygous mutations in genes associated with parkinsonism","volume":"6","author":"Klein","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib45","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1523\/JNEUROSCI.2959-05.2005","article-title":"Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum","volume":"25","author":"Kreitzer","year":"2005","journal-title":"J.\u00a0Neurosci."},{"issue":"7128","key":"10.1016\/j.neuropharm.2015.10.021_bib46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(02)00777-8","article-title":"Selective replenishment of two vesicle pools depends on the source of Ca2+ at the Drosophila synapse","volume":"35","author":"Kuromi","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib48","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1476-5381.2012.02175.x","article-title":"The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription","volume":"167","author":"Laprairie","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib49","series-title":"Handbook of Basal Ganglia Structure and Function","article-title":"Endocannabinoid signaling in the striatum","author":"Lovinger","year":"2010"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib50","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","article-title":"Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum","volume":"58","author":"Lovinger","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib52","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1242\/jcs.02536","article-title":"Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction","volume":"118","author":"Maccarrone","year":"2005","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2009.05948.x","article-title":"Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum","volume":"109","author":"Maccarrone","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tibs.2010.05.008","article-title":"Intracellular trafficking of anandamide: new concepts for signaling","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrn3846","article-title":"Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies","volume":"15","author":"Maccarrone","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.10.021_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.25724","article-title":"PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity","volume":"29","author":"Madeo","year":"2014","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.neuropharm.2015.10.021_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/humu.20719","article-title":"PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum","volume":"29","author":"Marongiu","year":"2008","journal-title":"Hum. Mutat."},{"issue":"3","key":"10.1016\/j.neuropharm.2015.10.021_bib58","first-page":"66","article-title":"Endocannabinoid-dopamine interactions in striatal synaptic plasticity","volume":"19","author":"Mathur","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2005.09.005","article-title":"Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia","volume":"137","author":"Matyas","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/emmm.200900006","article-title":"Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function","volume":"1","author":"Morais","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib61","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1100\/tsw.2008.136","article-title":"Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer","volume":"8","author":"Navarro","year":"2008","journal-title":"Sci. World J."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.10.021_bib62","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1124\/mol.107.039263","article-title":"CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a","volume":"72","author":"Niehaus","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib63","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2015.10.021_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5381.2009.00310.x","article-title":"Central antinociception induced by mu-opioid receptor agonist morphine, but not delta- or kappa-, is mediated by cannabinoid CB1 receptor","volume":"158","author":"Pacheco","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"42","key":"10.1016\/j.neuropharm.2015.10.021_bib65","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.2149-10.2010","article-title":"Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition","volume":"30","author":"Paill\u00e9","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib66","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib67","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF02244248","article-title":"Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats","volume":"103","author":"Paulson","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","volume":"168","author":"Pertwee","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib69","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/mds.23457","article-title":"Homeostatic changes of the endocannabinoid system in Parkinson's disease","volume":"26","author":"Pisani","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib70","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1073\/pnas.0709336105","article-title":"The PINK1\/Parkin pathway regulates mitochondrial morphology","volume":"105","author":"Poole","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus","volume":"21","author":"Rodriguez","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib72","doi-asserted-by":"crossref","first-page":"e29239","DOI":"10.1371\/journal.pone.0029239","article-title":"Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons","volume":"7","author":"Rozenfeld","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib73","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","article-title":"Parkin and PINK1: much more than mitophagy","volume":"37","author":"Scarffe","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib74","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1476-5381.2010.00777.x","article-title":"Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?","volume":"160","author":"Smith","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2015.10.021_bib75","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.conb.2009.10.003","article-title":"Dopamine and synaptic plasticity in dorsal striatal circuits controlling action selection","volume":"19","author":"Surmeier","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib76","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0306-4522(97)00597-6","article-title":"Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum","volume":"85","author":"Szabo","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib77","doi-asserted-by":"crossref","first-page":"e11038","DOI":"10.1371\/journal.pone.0011038","article-title":"Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine","volume":"5","author":"Thompson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2015.10.021_bib78","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1523\/JNEUROSCI.0448-07.2007","article-title":"Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum","volume":"27","author":"Uchigashima","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2015.10.021_bib79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","article-title":"Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment","volume":"206","author":"Urig\u00fcen","year":"2009","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib80","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ana.20256","article-title":"PINK1 mutations are associated with sporadic early-onset parkinsonism","volume":"56","author":"Valente","year":"2004","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.neuropharm.2015.10.021_bib81","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A\u00a0role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib82","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/01.wnl.0000338699.56379.11","article-title":"Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype","volume":"72","author":"Van Neunen","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuropharm.2015.10.021_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.celrep.2014.12.005","article-title":"Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum","volume":"10","author":"Wu","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2015.10.021_bib84","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1471-4159.1996.67010352.x","article-title":"Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens","volume":"67","author":"Xue","year":"1996","journal-title":"J.\u00a0Neurochem."},{"issue":"21","key":"10.1016\/j.neuropharm.2015.10.021_bib85","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1073\/pnas.0510797103","article-title":"Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling","volume":"103","author":"Yin","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390815301441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:57:00Z","timestamp":1762214220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390815301441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":84,"alternative-id":["S0028390815301441"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}